ANI Pharmaceuticals, Inc.
ANIP
$61.46
-$1.81-2.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -989.70% | -343.12% | -136.62% | 1,165.25% | 127.22% |
| Total Depreciation and Amortization | 48.74% | 3.56% | 0.05% | -0.10% | -2.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,846.54% | 541.48% | 48.09% | -162.32% | -88.22% |
| Change in Net Operating Assets | -128.80% | 107.55% | 33.06% | -476.38% | 233.88% |
| Cash from Operations | -64.55% | -61.22% | -15.57% | -14.73% | 1,116.82% |
| Capital Expenditure | -5.05% | -176.71% | -77.89% | -95.02% | 27.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.56% | 77.58% | -- | -- | -62,400.00% |
| Cash from Investing | -123.50% | -8,652.95% | 34.82% | 479.64% | -52.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 79.20% | -39,150.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -13.66% | -78.64% | -98.77% | 1,550.32% | 156.38% |
| Repurchase of Common Stock | -37.66% | -1.49% | -142.09% | -144.04% | -94.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.00% | 0.00% | 0.00% | 0.25% |
| Other Financing Activities | 54.18% | -- | -- | -- | -- |
| Cash from Financing | 58.83% | 7,650.47% | -101.81% | -333.73% | -2,246.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.44% | -403.12% | -87.75% | -48.52% | 448.36% |
